The Use of Emerging Safety Biomarkers in Nonclinical and Clinical Safety Assessment - the Current and Future State: An IQ DruSafe Industry Survey

The Use of Emerging Safety Biomarkers in Nonclinical and Clinical Safety Assessment – the Current and Future State: An IQ DruSafe Industry Survey

Pharmaceutical and biotechnology firms hardly ever disclose their use of translational rising security biomarkers (ESBs) throughout drug improvement, and the affect of ESB use on the velocity of drug improvement stays unclear. A cross-industry survey of 20 firms of various measurement was performed to know present tendencies in ESB use and future use prospects. The goals had been to: […]